TREOSULFAN (DIHYDROXYBUSULPHAN) IN THE MANAGEMENT OF OVARIAN CARCINOMA
- 1 April 1977
- journal article
- Published by Wiley in BJOG: An International Journal of Obstetrics and Gynaecology
- Vol. 84 (4) , 300-303
- https://doi.org/10.1111/j.1471-0528.1977.tb12581.x
Abstract
Of 36 patients with ovarian carcinoma treated with treosulfan (dihydroxybusulphan) 30·5 per cent had a complete response for a mean of 19·0 months and 33·3 per cent had a partial response. Treosulfan may have a role in the management of ascites associated with ovarian neoplasm.Keywords
This publication has 8 references indexed in Scilit:
- The chemotherapy of ovarian carcinomaCancer Treatment Reviews, 1974
- Treosulfan in the Treatment of Ovarian Carcinoma1Acta Obstetricia et Gynecologica Scandinavica, 1973
- Ovarian Carcinoma Treatment with TreosulfanActa Obstetricia et Gynecologica Scandinavica, 1973
- Treatment of Ovarian Cancer with TreosulfanActa Obstetricia et Gynecologica Scandinavica, 1973
- Treatment of Ovarian Carcinoma: Possibilities for ProgressNew England Journal of Medicine, 1972
- OVER-ALL EVALUATION OF CHEMOTHERAPY FOR OVARIAN CANCERClinical Obstetrics and Gynecology, 1969
- The changing prognosis and treatment in cancer of the ovaryAmerican Journal of Obstetrics and Gynecology, 1968
- 1,4-Bismethanesulfonates of the Stereoisomeric Butanetetraols and Related CompoundsJournal of Medicinal Chemistry, 1964